1-2 of 2
for the Intergroupe Francophone du Myélome
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Translocation t(14;16) and multiple myeloma: is it really an independent prognostic factor?

Brief Report
Hervé Avet-Loiseau, Florent Malard, Loic Campion, Florence Magrangeas, Catherine Sebban, Bruno Lioure, Olivier Decaux, Thierry Lamy, Laurence Legros, Jean-Gabriel Fuzibet, Mauricette Michallet, Bernadette Corront, Pascal Lenain, Cyrille Hulin, Claire Mathiot, Michel Attal, Thierry Facon, Jean-Luc Harousseau, Stephane Minvielle, Philippe Moreau, for the Intergroupe Francophone du Myélome
Journal: Blood
Blood (2011) 117 (6): 2009–2011.
https://doi.org/10.1182/blood-2010-07-295105
Published: 2011
Journal Articles

Bortezomib and high-dose melphalan as conditioning regimen before autologous stem cell transplantation in patients with de novo multiple myeloma: a phase 2 study of the Intergroupe Francophone du Myélome (IFM)

Clinical Trials & Observations
Murielle Roussel, Philippe Moreau, Anne Huynh, Jean-Yves Mary, Clotaire Danho, Denis Caillot, Cyrille Hulin, Christophe Fruchart, Gérald Marit, Brigitte Pégourié, Pascal Lenain, Carla Araujo, Brigitte Kolb, Edouard Randriamalala, Bruno Royer, Anne-Marie Stoppa, Mammoun Dib, Véronique Dorvaux, Laurent Garderet, Claire Mathiot, Hervé Avet-Loiseau, Jean-Luc Harousseau, Michel Attal, for the Intergroupe Francophone du Myélome (IFM)
Journal: Blood
Blood (2010) 115 (1): 32–37.
https://doi.org/10.1182/blood-2009-06-229658
Published: 2010